SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042925
Filing Date
2019-11-12
Accepted
2019-11-12 16:16:27
Documents
61
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mack-10q_20190930.htm 10-Q 1717454
2 EX-31.1 mack-ex311_9.htm EX-31.1 9498
3 EX-31.2 mack-ex312_8.htm EX-31.2 9499
4 EX-32.1 mack-ex321_13.htm EX-32.1 5660
5 EX-32.2 mack-ex322_7.htm EX-32.2 5656
  Complete submission text file 0001564590-19-042925.txt   5300083

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mack-20190930.xml EX-101.INS 972861
7 XBRL TAXONOMY EXTENSION SCHEMA mack-20190930.xsd EX-101.SCH 41112
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mack-20190930_cal.xml EX-101.CAL 49928
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mack-20190930_def.xml EX-101.DEF 123985
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mack-20190930_lab.xml EX-101.LAB 321640
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mack-20190930_pre.xml EX-101.PRE 249580
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Filer) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35409 | Film No.: 191209635
SIC: 2834 Pharmaceutical Preparations